-
Mashup Score: 1Annals for Hospitalists - March 2024 | Annals of Internal Medicine - 1 month(s) ago
Can’t sign in? Forgot your password? If the address matches an exis ting account you will receive an email with instructions to reset your password. Can’t sign in? Forgot your username? Ann Intern Med. 2024;177:343-352. Published 27 February 2024. doi:10.7326/M23-2593 The ACTT-2 (Adaptive COVID-19 Treatment Trial-2) was a randomized controlled trial that investigated the use of baricitinib for treating hospitalized patients with COVID-19. That trial showed that baricitinib plus remdesivir improved
Source: www.acpjournals.orgCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 1Annals for Hospitalists - March 2024 | Annals of Internal Medicine - 1 month(s) ago
Can’t sign in? Forgot your password? If the address matches an exis ting account you will receive an email with instructions to reset your password. Can’t sign in? Forgot your username? Ann Intern Med. 2024;177:343-352. Published 27 February 2024. doi:10.7326/M23-2593 The ACTT-2 (Adaptive COVID-19 Treatment Trial-2) was a randomized controlled trial that investigated the use of baricitinib for treating hospitalized patients with COVID-19. That trial showed that baricitinib plus remdesivir improved
Source: www.acpjournals.orgCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 6
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t sign in? Forgot your username? From University of Michigan, Ann Arbor, Michigan (D.A.F.) Ann Intern Med. 2023;176:ITC177-IT C192. Published 12 December 2023. doi:10.7326/AITC202312190 This article provides a narrative review of the current evidence regarding diagnosis and treatment of heart failure in the hospital. Patients admitted for decompensated
Source: www.acpjournals.orgCategories: General Medicine News, General HCPsTweet
In a new #AnnalsForHospitalists, learn about baricitinib for #COVID19, low GFR, and more: https://t.co/vBNhQ5AKI0 https://t.co/oroOoxMrrE